Cardiac imaging
"Magnetic resonance imaging" (originally called nuclear magnetic resonance imaging), an imaging methodology based on aligning the spin axis of nuclei within molecules of the object being visualized using both powerful superconducting magnets and radio frequency and detectors. Cardiology uses are growing, especially since MRI differentiates soft tissues better than CT and allows for comprehensive exams including the quantitative assessment of size, morphology, function, and tissue characteristics in one single session. Current implementations for Cardiology uses are sometimes limited by lengthy protocols, claustrophobia and contraindications based on some complex metallic implants (pacemakers, defibrillators, insulin pumps), while artificial valves and coronary stents are generally not problematic. Image quality can be reduced by the continuous movement of heart structures. There is a promising future in cardiac MRI by more efficient scans, increasing availability of scanners and more widespread knowledge about its clinical application.
TeraView
Due in part to its ability to recognize spectral fingerprints, terahertz pulsed imaging can be applied to provide contrast between different types of soft tissue. Also, it is a sensitive means of detecting the degree of water content and markers of cancer and other diseases. Attempts have been made to apply Terahertz to image cancers like breast, cancer as well as other diseases in medicine, oral health care, and related areas. The company announced it has been cleared by the Medicines and Healthcare products Regulatory Agency (MHRA) to trial "in-vivo" terahertz spectroscopy for bio-medical research. The trials will be held in Guy's Hospital in London and aim to determine if the technology can be applied real-time for accurate removal of cancer tissue.